Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02157051
Recruitment Status : Recruiting
First Posted : June 5, 2014
Last Update Posted : June 22, 2017
United States Department of Defense
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2022
  Estimated Study Completion Date : February 2022